Mutares stock holds after H1 2026 EBITDA jumped

Mutares stock is anchored by H1 2026 sales of EUR 3.4 billion and adjusted EBITDA of EUR 67 million, with bond-covenant compliance restored by June 30, 2026.

Mutares SE & Co KGaA (ISIN DE000A0Z23Y2) comes into August 26, 2026 with H1 2026 sales of EUR 3.4 billion and adjusted EBITDA of EUR 67 million, while reported EBITDA reached EUR 349 million. The shares are being read through that combination of portfolio income and a newly restored balance-sheet marker after bond-covenant compliance was re-established by June 30, 2026.

H1 figures set the tone

The clearest current comparison is the adjusted EBITDA jump of more than EUR 150 million year over year, which points to a much stronger portfolio contribution than in the prior period. The same H1 update also said total group sales came in at EUR 3.4 billion, which gives the earnings base scale even before the second-half deal pipeline is counted.

Adjusted net income was EUR 6 million, down from EUR 70 million a year earlier, so the headline EBITDA improvement did not flow through evenly to the bottom line. That gap matters because Mutares continues to depend on exits, acquisitions and portfolio turnaround work to translate operating progress into shareholder earnings.

Second-half catalysts

The latest H1 call also pointed to the acquisition of SABIG, renamed NexPoint, and said the business should add to revenue and EBITDA in H2 2026. It also flagged the NEM exit for Q3 2026 and said the transaction is expected to have an impact of north of EUR 100 million on adjusted net income.

For investors, the key issue is whether those steps convert into cleaner reported earnings after the first-half mix of stronger operating performance and weaker net income. The company said it expects significant buy-side and sell-side activity in the second half, so the next catalyst is more likely to come from execution than from a new strategy statement.

Portfolio moves

Nord Gas Solutions remains one of the more concrete growth references in the current update. The business was described as generating turnover in a range of EUR 400 million to EUR 500 million and EBITDA north of EUR 30 million in the first seven months, which makes it a visible contributor inside the wider industrial portfolio.

What the shares reflect

Mutares stock is trading against those H1 numbers and the H2 deal pipeline as of August 26, 2026. The market is weighing a reported EBITDA of EUR 349 million, adjusted EBITDA of EUR 67 million and adjusted net income of EUR 6 million against the prospect of further portfolio closes and exits in the coming quarter.

Investor relations

Company: Mutares SE & Co KGaA
ISIN: DE000A0Z23Y2
Ticker: MUXG
Exchange: Frankfurt / Tradegate
Sector / Industry: Financials / Asset Management & Custody Banks

Mutares share context

Market cap, price and 52-week range were not carried in the supported results for this call, so the article stays anchored to the dated H1 2026 operating figures and the stated Q3 2026 exit timing.